Followers | 177 |
Posts | 24554 |
Boards Moderated | 13 |
Alias Born | 04/03/2002 |
Tuesday, May 02, 2023 8:23:15 AM
8:00 am ET May 2, 2023 (BusinessWire)
P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ: PIII), a patient-centered and physician-led population health management company, announces that the Company plans to release its financial results for first-quarter 2023 and file its quarterly report on Form 10-Q on Wednesday, May 10, 2023. In connection with this release, management will host a conference call and webcast to provide a corporate and financial update:
Title & Webcast P3 Health First-Quarter 2023 Earnings Conference Call
------------------------ ------------------------------------------------------
Date & Time May 10, 2023, 4:30pm Eastern Time
------------------------ ------------------------------------------------------
Conference Call Details Toll-Free 1-877-270-2148 (US)
International 1-412-902-6510
Ask to be joined into the P3 Health Partners call
------------------------ ------------------------------------------------------
About P3 Health Partners (NASDAQ: PIII):
P3 Health Partners Inc. is a leading population health management company committed to transforming healthcare by improving the lives of both patients and providers. Founded and led by physicians, P3 has an expansive network of more than 2,800 affiliated primary care providers across the country. Our local teams of health care professionals manage the care of thousands of patients in 15 counties across five states. P3 supports primary care providers with value-based care coordination and administrative services that improve patient outcomes and lower costs. Through partnerships with these local providers, the P3 care team creates an enhanced patient experience by navigating, coordinating, and integrating the patient's care within the healthcare system. For more information, visit www.p3hp.org and follow us on LinkedIn and Facebook.com/p3healthpartners
View source version on businesswire.com: https://www.businesswire.com/news/home/20230502005292/en/
SOURCE: P3 Health Partners Inc.
Kassi Belz, Executive Vice President Communications
P3 Health Partners
(904) 415-2744
kbelz@p3hp.org
Investor Relations
Karen Blomquist
Vice President, Investor Relations
P3 Health Partners
kblomquist@p3hp.org
Recent PIII News
- P3 Health Partners Inc. Announces Approximately $42.2 Million Private Placement • Business Wire • 05/23/2024 12:00:00 PM
- P3 Health Partners Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 05/09/2024 09:26:00 PM
- P3 Health Partners Names Dr. Aric Coffman as CEO • Business Wire • 05/08/2024 08:05:00 PM
- P3 Health Partners Announces First Quarter 2024 Results • Business Wire • 05/08/2024 08:05:00 PM
- P3 Health Partners Schedules First Quarter 2024 Earnings Release and Conference Call • Business Wire • 05/02/2024 12:00:00 PM
- P3 Health Partners to Present at the 23rd Annual Needham Virtual Healthcare Conference • Business Wire • 04/03/2024 12:00:00 PM
- P3 Health Partners Announces Fourth Quarter and Full Year 2023 Results • Business Wire • 03/28/2024 08:05:00 PM
- P3 Health Partners to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024 • Business Wire • 03/15/2024 12:00:00 PM
- P3 Health Partners to Present at the KeyBanc LifeSciences & Medtech Investor Forum • Business Wire • 03/07/2024 01:00:00 PM
- P3 Health Partners to Participate in the Jefferies Value Based Healthcare Summit • Business Wire • 02/28/2024 01:00:00 PM
- P3 Health Partners to Present at the TD Cowen 44th Annual Healthcare Conference • Business Wire • 02/19/2024 01:00:00 PM
- P3 Health Partners to Participate in The 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference • Business Wire • 01/30/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2024 10:26:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2024 10:26:02 PM
- P3 Health Partners Reaffirms Guidance for 2023 and Announces Guidance for 2024 • Business Wire • 01/10/2024 12:29:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 10:31:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 10:30:54 PM
- P3 Health Partners to Present at the 42nd Annual J.P. Morgan Healthcare Conference • Business Wire • 01/02/2024 10:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/21/2023 11:02:01 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/21/2023 11:00:44 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/21/2023 05:15:15 AM
- P3 Health Partners to Present at the BTIG Digital Health Forum • Business Wire • 11/16/2023 12:00:00 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 11/09/2023 10:19:07 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM